VitaCig, Inc. Expands International Market - Signs Agreement for Japan Distribution worth $1.3M over Next Three Years
23 Maggio 2016 - 1:00PM
InvestorsHub NewsWire
Beverly Hills, CA --
May 23, 2016 -- InvestorsHub NewsWire -- VitaCig, Inc. (OTC
PINK: VTCQ), a technology company that is harnessing mobile
vaporization technology for multiple delivery applications, as well
as a leader in the development, marketing, and sale of ultra-pure
CBD Tinctures, Edibles, Concentrates, and E-Liquids is pleased to
announce further international expansion by securing a three year
distribution agreement for Japan with a minimum purchase of $1.3M
over the next three years.
Fresh off the heels of
closing a $1.35M three year contract for China, VitaCig Inc. has
closed yet again another lucrative exclusive international
contract, this time for Japan. A country highly recognized as
having abnormally high rate of smoking.
Glenn Kassell CEO
comments, “I am extremely pleased to announce our agreement with
Mr. Masayuki Eshika, CEO of Crearesse Inc., along with
International Merchandise Consultants for the distribution and sale
of our premier line of products in Japan. Focusing on both national
and international expansion will be a key path forward for long
term growth and success. It is important for shareholders and
the investment community to understand that this aggressive focus
on international markets is not by accident. Having been expecting
new Federal e-cig regulations to come down for some time, our team
has been relentless in pursuing and securing international
contracts, where e-cig regulation may not be as harsh. With our
company now offering both nicotine and non-nicotine based products,
it is important that our team establish distribution channels for
both product lines. Our commitment to international development
will ensure our business opportunities stay strong.”
New VitaCig
International Partner Mr. Masayuki Eshika comments, “I am extremely
excited about the new partnership with VitaCig Inc., the maker of
the original Vitamin Vaporizer. “I am honored to have the ability
to offer a healthier alternative to tar and tobacco based products,
and taking into consideration the overwhelming initial interest, we
are looking forward to a very lucrative partnership with the team
at VitaCig.”
VitaCig continues to
expand its intellectual property on a global basis as it continues
to strengthen its brand worldwide.
The fact that the VitaCig®
was the very "first" and
"original", vitamin vaporizer to market, offers our international
distributors the marketing and branding edge they need to comptete
against similar branded products now available on the market
place. VitaCig is currently in negotiations
to lock in similar deals for its VitaCig brand and products for
India, UAE, Kuwait, South Africa, Canada, Asia, Latin America, and
U.S. territories. In addition, our partner in Europe continues
product expansion throughout EU, including new markets like
Switzerland, Australia, and Spain, expected to come online during
the second quarter of our fiscal year.
Lastly, the all new
VitaCig18® Nicotine Edition and new VitaCig® Succulent Strawberry
flavor is now available for pre-sale discount on our
http://www.vitacig.org/
website.
Stay tuned for future
updates!
About
VitaCig, Inc.
VitaCig, Inc. (OTC
PINK: VTCQ) is a technology company harnessing mobile
vaporization technology for medical delivery applications. The
company owns, manufactures, and distributes the VitaCig®, a
nicotine-free device. As well as a leader in the development,
marketing, and sale of ultra-pure CBD Oil tinctures, Edibles, and
E-Liquids.
The company's products
are sold online at: www.mcig.org,
www.vitacbd.com,
www.vitacig.org,
or through affiliate websites and select brick and mortar
locations.
Safe Harbor
Statement
Any statements contained
in this press release that do not describe historical facts may
constitute forward-looking statements as that term is defined in
the Private Securities Litigation Reform Act of 1995. Any
forward-looking statements contained herein are based on current
expectations, but are subject to a number of risks and
uncertainties. The factors that could cause actual future results
to differ materially from current expectations include, but are not
limited to, risks and uncertainties relating to the Company's
ability to develop, market and sell products based on its
technology; the expected benefits and efficacy of the Company's
products and technology; the availability of substantial additional
funding for the Company to continue its operations and to conduct
research and development, and future product commercialization; and
the Company's business, research, product development, regulatory
approval, marketing and distribution plans and
strategies.
Contact:
VitaCig, Inc.
Glenn Kassel
CEO
Glenn@vitacig.org
Grafico Azioni Omni Health (CE) (USOTC:OMHE)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni Omni Health (CE) (USOTC:OMHE)
Storico
Da Set 2023 a Set 2024